Dementia: A neuroendocrine perspective

A. Polleri, M. V. Gianelli, Giovanni Murialdo

Research output: Contribution to journalArticle

Abstract

The etiology of Alzheimer's disease (AD) has not been as yet completely defined. Genetic, environmental and neurophysiological aspects should all be taken into account. The disease has also neuroendocrine implications, some of which are discussed in this review. It is known that stress and glucocorticoids may affect neurone survival. On the contrary, some data indicate that DHEA and DHEAS exert a neuroprotective action. In AD, changes in hypothalamic-pituitary-adrenal axis function have been reported. Experimental and clinical evidence indicates that glucocorticoid hypersecretion and DHEAS levels decrement may add to hippocampal dysfunction in aging and in AD. Glucocorticoid and β-amyloid concur in the mechanism of neurone damage, as well as excitatory amino acids (EAA), Ca ++ and reactive oxygen species (ROS). The neuroprotective effects exerted by IGFs are also hindered in aging and even more in AD. Production and biological actions of IGFs are negatively influenced by cortisol hypersecretion and DHEAS decrease in patients with AD.

Original languageEnglish
Pages (from-to)73-83
Number of pages11
JournalJournal of Endocrinological Investigation
Volume25
Issue number1
Publication statusPublished - 2002

Fingerprint

Dementia
Alzheimer Disease
Glucocorticoids
Neurons
Excitatory Amino Acids
Dehydroepiandrosterone
Neuroprotective Agents
Amyloid
Hydrocortisone
Reactive Oxygen Species

Keywords

  • Aging
  • Alzheimer's disease
  • Cortisol
  • DHEAS
  • Hippocampus
  • IGF-I
  • Neurodegenerative diseases
  • Neurosteroids
  • Sex hormones

ASJC Scopus subject areas

  • Endocrinology

Cite this

Polleri, A., Gianelli, M. V., & Murialdo, G. (2002). Dementia: A neuroendocrine perspective. Journal of Endocrinological Investigation, 25(1), 73-83.

Dementia : A neuroendocrine perspective. / Polleri, A.; Gianelli, M. V.; Murialdo, Giovanni.

In: Journal of Endocrinological Investigation, Vol. 25, No. 1, 2002, p. 73-83.

Research output: Contribution to journalArticle

Polleri, A, Gianelli, MV & Murialdo, G 2002, 'Dementia: A neuroendocrine perspective', Journal of Endocrinological Investigation, vol. 25, no. 1, pp. 73-83.
Polleri A, Gianelli MV, Murialdo G. Dementia: A neuroendocrine perspective. Journal of Endocrinological Investigation. 2002;25(1):73-83.
Polleri, A. ; Gianelli, M. V. ; Murialdo, Giovanni. / Dementia : A neuroendocrine perspective. In: Journal of Endocrinological Investigation. 2002 ; Vol. 25, No. 1. pp. 73-83.
@article{42ef71b0b8654f2ab53b22c78d8b021a,
title = "Dementia: A neuroendocrine perspective",
abstract = "The etiology of Alzheimer's disease (AD) has not been as yet completely defined. Genetic, environmental and neurophysiological aspects should all be taken into account. The disease has also neuroendocrine implications, some of which are discussed in this review. It is known that stress and glucocorticoids may affect neurone survival. On the contrary, some data indicate that DHEA and DHEAS exert a neuroprotective action. In AD, changes in hypothalamic-pituitary-adrenal axis function have been reported. Experimental and clinical evidence indicates that glucocorticoid hypersecretion and DHEAS levels decrement may add to hippocampal dysfunction in aging and in AD. Glucocorticoid and β-amyloid concur in the mechanism of neurone damage, as well as excitatory amino acids (EAA), Ca ++ and reactive oxygen species (ROS). The neuroprotective effects exerted by IGFs are also hindered in aging and even more in AD. Production and biological actions of IGFs are negatively influenced by cortisol hypersecretion and DHEAS decrease in patients with AD.",
keywords = "Aging, Alzheimer's disease, Cortisol, DHEAS, Hippocampus, IGF-I, Neurodegenerative diseases, Neurosteroids, Sex hormones",
author = "A. Polleri and Gianelli, {M. V.} and Giovanni Murialdo",
year = "2002",
language = "English",
volume = "25",
pages = "73--83",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "1",

}

TY - JOUR

T1 - Dementia

T2 - A neuroendocrine perspective

AU - Polleri, A.

AU - Gianelli, M. V.

AU - Murialdo, Giovanni

PY - 2002

Y1 - 2002

N2 - The etiology of Alzheimer's disease (AD) has not been as yet completely defined. Genetic, environmental and neurophysiological aspects should all be taken into account. The disease has also neuroendocrine implications, some of which are discussed in this review. It is known that stress and glucocorticoids may affect neurone survival. On the contrary, some data indicate that DHEA and DHEAS exert a neuroprotective action. In AD, changes in hypothalamic-pituitary-adrenal axis function have been reported. Experimental and clinical evidence indicates that glucocorticoid hypersecretion and DHEAS levels decrement may add to hippocampal dysfunction in aging and in AD. Glucocorticoid and β-amyloid concur in the mechanism of neurone damage, as well as excitatory amino acids (EAA), Ca ++ and reactive oxygen species (ROS). The neuroprotective effects exerted by IGFs are also hindered in aging and even more in AD. Production and biological actions of IGFs are negatively influenced by cortisol hypersecretion and DHEAS decrease in patients with AD.

AB - The etiology of Alzheimer's disease (AD) has not been as yet completely defined. Genetic, environmental and neurophysiological aspects should all be taken into account. The disease has also neuroendocrine implications, some of which are discussed in this review. It is known that stress and glucocorticoids may affect neurone survival. On the contrary, some data indicate that DHEA and DHEAS exert a neuroprotective action. In AD, changes in hypothalamic-pituitary-adrenal axis function have been reported. Experimental and clinical evidence indicates that glucocorticoid hypersecretion and DHEAS levels decrement may add to hippocampal dysfunction in aging and in AD. Glucocorticoid and β-amyloid concur in the mechanism of neurone damage, as well as excitatory amino acids (EAA), Ca ++ and reactive oxygen species (ROS). The neuroprotective effects exerted by IGFs are also hindered in aging and even more in AD. Production and biological actions of IGFs are negatively influenced by cortisol hypersecretion and DHEAS decrease in patients with AD.

KW - Aging

KW - Alzheimer's disease

KW - Cortisol

KW - DHEAS

KW - Hippocampus

KW - IGF-I

KW - Neurodegenerative diseases

KW - Neurosteroids

KW - Sex hormones

UR - http://www.scopus.com/inward/record.url?scp=0036177375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036177375&partnerID=8YFLogxK

M3 - Article

C2 - 11883869

AN - SCOPUS:0036177375

VL - 25

SP - 73

EP - 83

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 1

ER -